Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06681194 | NOT YET RECRUITING | Wound Healing

Silver Nitrate Vs. Triamcinolone for Treatment of Hypergranulation Tissue
Sponsor:

Francesco Egro

Information provided by (Responsible Party):

Francesco Egro

Brief Summary:

This randomized controlled trial aims to compare the efficacy of silver nitrate, triamcinolone, and a successive use of both treatments in managing hypergranulation tissue in traumatic wounds. Conducted over a four-year period at UPMC Mercy, the study will involve patients presenting with hypergranulation tissue. Participants will be randomly assigned to receive either topical silver nitrate, topical triamcinolone, or a combination of the two in succession. The study will assess treatment outcomes based on the reduction or resolution of hypergranulation tissue, with the goal of identifying the most effective therapeutic approach. This research will provide valuable insights into optimizing treatment strategies for hypergranulation tissue in traumatic wounds.

Condition or disease

Wound Healing

Granulation Tissue

Intervention/treatment

Silver Nitrate

triamcinolone

Silver nitrate + triamcinolone

Phase

PHASE2

PHASE3

Study Type : INTERVENTIONAL
Estimated Enrollment : 270 participants
Masking : NONE
Primary Purpose : TREATMENT
Official Title : A Comparative Study of Silver Nitrate, Triamcinolone, and Their Successive Combined Use on Hypergranulation Tissue in Traumatic Wounds: a Randomized Control Trial
Actual Study Start Date : 2025-01-01
Estimated Primary Completion Date : 2028-12-31
Estimated Study Completion Date : 2028-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Patients must be 18 years or older.
  • * Patients must be admitted to the institution with non-infected, traumatic wounds exhibiting hypergranulation tissue.
  • * Patients must provide consent to participate in the study.
  • * Eligible wounds include superficial or partial-thickness wounds.
  • * Wounds will be categorized based on size and depth, with variations controlled for in the statistical analysis.
Exclusion Criteria
  • * Patients with known allergies or contraindications to silver nitrate or triamcinolone.
  • * Patients with wounds that do not exhibit hypergranulation tissue.
  • * Patients with wounds not primarily due to traumatic injury (e.g., surgical wounds, pressure ulcers).
  • * Full-thickness, infected, or complex wounds will be excluded, as these may require different management strategies.
Silver Nitrate Vs. Triamcinolone for Treatment of Hypergranulation Tissue

Location Details

NCT06681194

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

Not yet recruiting

United States, Pennsylvania

UPMC Mercy Hospital

Pittsburgh, Pennsylvania, United States, 15213